Article
Prospective Evaluation of KIT Mutations and Long-Term Outcomes in Pediatric Core Binding Factor Acute Myeloid Leukemia: A Single Institutional Study in China.
Pediatric hematology and oncology - 1 Mar 2026
Hou Bei, Yang Feifei, Zhang Ruidong, Qin Maoquan, Li Jun, Wang Ying, Chen Hui, Li Jing, Qi Peijing, Jia Chenguang, Zheng Huyong, Gao Chao
Abstract excerpt
The overall incidence of core binding factor acute myeloid leukemia (CBF-AML) in pediatric patients has been reported to be 19%-44.3%. However, the prognostic role of KIT mutations in pediatric CBF-AML remains controversial. This study aimed to investigate whether incorporating KIT mutation status into risk stratification improves long-term outcomes. A total of 114 pediatric CBF-AML patients treated under BCH-AML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
